Samodzielny Publiczny Wojewodzki Szpital Zespolony W Szczecinie
- Address
- lock Available on a paid plan
Viral Diseases and HIV Research
At Samodzielny Publiczny Wojewodzki Szpital Zespolony W Szczecinie, clinical trials in virus diseases focus mainly on HIV-1 infection and broader HIV infections. These studies are exploring new treatment options, including oral regimens and switching strategies, to better control the virus and support long-term care.
- Evaluating new antiviral approaches for people living with HIV-1
- Comparing emerging oral therapies with current standard treatment for HIV
- Studying treatment options for both treatment-naive and virologically suppressed participants
This research aims to improve convenience, effectiveness, and overall management of chronic HIV care.
Respiratory Tract Diseases Research
The site also supports trials in respiratory tract diseases, with work centered on COVID-19 and idiopathic pulmonary fibrosis. These studies are designed to test new therapies and assess whether they can improve recovery, breathing function, and outcomes for patients with serious lung conditions.
- Testing immune-based treatment strategies for hospitalized patients with COVID-19
- Evaluating therapies aimed at improving lung function in idiopathic pulmonary fibrosis
- Studying treatment effectiveness in acute and chronic respiratory illness
This area reflects an emphasis on both urgent infection-related care and longer-term lung disease management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 therapeutic areas and 15 of 26 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Gilead Sciences Inc.2active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Gilead Sciences Inc.4trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Samodzielny Publiczny Wojewodzki Szpital Zespolony W Szczecinie
lock Showing 1 of 8 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b Randomized, Open-Label Active Controlled Study Evaluating the Safety and Efficacy of oral VH4524184 Coadministered with Emtricitabine and Tenofovir Alafenamide in Treatment Naïve Viremic Persons with HIV-1.( INNOVATE Study) | Viiv Healthcare UK Limited | Phase II | Recruiting | Feb 2026 | — |
IMP list
lock Showing 1 of 26 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Emtricitabine | 4 | Unknown | 2025-01-27 | 2026-02-11 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.